Foundation Medicine Announces 2015 First Quarter Results and Recent Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Foundation Medicine (FMI) Misses Q1 EPS by 6c
May 11, 2015 5:14 PM EDTFoundation Medicine (NASDAQ: FMI) reported Q1 EPS of ($0.59), $0.06 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $19.3 million versus the consensus estimate of $21 million.
Foundation Medicine sees FY2015 revenue of $105-115 million, versus the consensus of $108.7 million.
For earnings... More
